Altoida
- Digital health
Altoida is defining a new category in neurological care with a first-of-kind, multi-modal platform engineered to bring clinical-grade cognitive and functional diagnostics to the front lines of healthcare. Combining AR, AI & sensor fusion, Altoida's Digital NeuroMarker Platform delivers a 10-minute, self-administered assessment for both in-clinic and remote use, capturing hundreds of digital biomarkers across motor, speech, AR and cognitive domains. The platform is intended to detect signs of MCI and Alzheimer's disease earlier and more objectively than traditional clinical methods. Backed by over 20 years of scientific research, shaped by nearly 20,000 participants and tens of thousands of assessments, Altoida's platform is already being used in research by global pharmaceutical leaders to support clinical trial enrichment, optimized screening, treatment monitoring and disease progression research. Our work has been featured in Nature Digital Medicine and other leading journals.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}